Solera Introduces Weight Loss Solution to Help Payers and Employers Manage Skyrocketing GLP-1 Demand While Empowering Individuals to Make Informed Choices

2 years ago

GLP-1 Support from Solera can save tens of millions by streamlining step therapy and the prior authorization process for health…

Solid Biosciences to Participate at Upcoming Investor Conferences

2 years ago

CHARLESTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for…

Virbac : Declaration of the number of shares and voting rights 05/2023

2 years ago

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information…

Virbac : Declaration of the number of shares and voting rights 04/2023

2 years ago

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information…

Avenue Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference

2 years ago

MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company…

ReWalk Robotics Announces Additional Change to Board of Directors

2 years ago

Number of Director Seats to be Reduced to SevenMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept. 05, 2023 (GLOBE…

Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors

2 years ago

Dorothy Clarke Dorothy Clarke CAMBRIDGE, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the…

Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

2 years ago

CHARLOTTESVILLE, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage…

SomaLogic expands agreement with Novo Nordisk to 2025

2 years ago

Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseasesBOULDER, Colo., Sept.…

IMUNON to Participate in the H.C. Wainwright Global Investment Conference

2 years ago

LAWRENCEVILLE, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announces that management will…